Starling Oncology (STLN)
Starling Oncology, Inc., an oncology company, provides various oncology services in the United States. It operates through three segments: Specialty pharmacy, P...
- Open
- 6.230
- High
- 6.525
- Low
- 6.090
- Prev. Close
- 6.160
- Volume
- 1.50M
- Turnover
- 9.43M
- Avg Price
- 6.297
- Bid/Ask Ratio
- 92.22%
- Amplitude
- 7.06%
- 52wk High
- 7.050
- Volume Ratio
- 0.00
- Turnover Ratio
- 1.70%
Starling Oncology Analyst Rating
View moreForecast & Rating
Aug 10, 2026Price forecast
$9.0045.63%
Forecast & RatingStrong buy
5analysts
- Strong buy80.00%
- Buy20.00%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
News
- Price Alert · 1 day ago, 04:33 AM
Pre-market hot trades in US stocks: Starling Oncology up 7.66% in pre-market; Smart Logistics Global down 7.66% in pre-market
- benzinga_article · Aug 7 at 12:53 PM
Starling Oncology shares are trading higher after the company reported a year-over-year decrease in Q2 loss per share and increase in sales results.
- benzinga_article · Aug 7 at 12:05 PM
12 Health Care Stocks Moving In Friday's Intraday Session
- benzinga_article · Aug 7 at 07:05 AM
12 Health Care Stocks Moving In Friday's Pre-Market Session
- PUBT · Aug 6 at 04:50 PM
Starling Oncology lifts FY 2026 revenue outlook to $650-$670 million
- PUBT · Aug 6 at 04:46 PM
Oncology Institute Q2 FY26 net loss narrows 42.4% to $9.79 million; revenue rises 34.6% to $161.28 million
